Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market

17th October 2023 Uncategorised 0

Lilly, AbbVie, BMS and more rally against UK’s ‘arbitrary’ growth cap on branded drug market
fkansteiner
Tue, 10/17/2023 – 14:53

More: Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
Source: fierce